Previous close | 234.60 |
Open | 234.03 |
Bid | 0.00 x 1100 |
Ask | 0.00 x 800 |
Day's range | 232.46 - 236.09 |
52-week range | 229.40 - 287.32 |
Volume | |
Avg. volume | 1,315,877 |
Market cap | 67.522B |
Beta (5Y monthly) | 0.46 |
PE ratio (TTM) | 53.48 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.80 (1.63%) |
Ex-dividend date | 10 June 2024 |
1y target est | N/A |
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $0.95 per common share, payable on June 28, 2024 to holders of record on June 10, 2024. The indicated annual dividend rate is $3.80 per share.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 11:00 am Eastern Time.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health "Best Employers: Excellence in Health & Well-being Award" for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives.